Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 31769030 approvals

QuantaMatrix Incorporated

Official website

Established in 2010, listed on KOSDAQ in 2020, QuantaMatrix develops dRAST and QDST antimicrobial susceptibility testing systems.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

QuantaMatrix Incorporated was established on November 29, 2010 and listed on KOSDAQ on December 9, 2020 as an in vitro diagnostics (IVD) medical device company. Based on microbial diagnostic technology, it develops and produces the dRAST automated rapid antimicrobial susceptibility testing system with dRAST GN S17 and GP S17 test kits, and the QDST automated rapid anti-tuberculosis susceptibility testing system with the QMAC-DST13 test kit. The company researches, manufactures, and sells these in vitro diagnostic devices for tertiary general hospitals and reference laboratories in Korea and abroad, and is also pursuing commercialization of medical devices for early disease diagnosis and prognosis prediction based on its own molecular immunodiagnostic testing platform.

Products & technology

  • dRASTAutomated rapid antimicrobial susceptibility testing system
  • dRAST GN S17 / GP S17Rapid antimicrobial susceptibility test kit
  • QDSTAutomated rapid anti-tuberculosis susceptibility testing system
  • QMAC-DST13Rapid anti-tuberculosis susceptibility test kit

Regulatory approvals

data.go.kr

30 Korean MFDS device approvals · 2014–2026

  • MFDSMicrobial susceptibility testing analyzer2026-01-20
    Product approval · Class 1체외 제신 26-77 호
  • MFDSMicrobial identification analyzer2022-09-28
    Product approval · Class 1체외 수신 22-1645 호
  • MFDSMicrobial identification analyzer2022-09-21
    Product approval · Class 1체외 수신 22-1611 호
  • MFDSIVD reagents and media for antibiotic susceptibility2022-04-13
    Product approval · Class 2체외 제인 22-4292 호
  • MFDSIVD reagents for general immune test2021-11-04
    Product approval · Class 2체외 제인 21-4937 호
  • MFDSIVD reagents for staining or culturing clinical microbiology2021-07-23
    Product approval · Class 1체외 제신 21-1019 호
  • MFDSIVD reagents and media for antibiotic susceptibility2021-06-18
    Product approval · Class 2체외 제인 21-4533 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2021-06-18
    Product approval · Class 2체외 제인 21-4532 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2021-05-06
    Product approval · Class 3체외 제허 21-353 호
  • MFDSIVD reagents and media for antibiotic susceptibility2021-02-23
    Product approval · Class 2체외 제인 21-4144 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2020-09-24
    Product approval · Class 3체외 제허 20-838 호
  • MFDSIVD reagents for general immune test2020-07-20
    Product approval · Class 2체외 제허 20-589 호
Show 18 more
  • MFDSIVD reagents for general immune testRevoked2020-06-02
    Product approval · Class 2체외 제허 20-430 호
  • MFDSFluorometer for clinical use2020-01-06
    Product approval · Class 1체외 제신 20-15 호
  • MFDSIVD reagents and media for antibiotic susceptibility2018-06-05
    Product approval · Class 2체외 제인 18-4422 호
  • MFDSIVD reagents and media for antibiotic susceptibility2018-03-30
    Product approval · Class 2체외 제인 18-4248 호
  • MFDSIVD reagents and media for antibiotic susceptibility2018-02-05
    Product approval · Class 2체외 제인 18-4086 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2018-01-08
    Product approval · Class 3체외 제허 18-11 호
  • MFDSIVD reagents for inflammatory testsRevoked2017-12-19
    Product approval · Class 2체외 제인 17-4985 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2017-11-15
    Product approval · Class 3체외 제허 17-872 호
  • MFDSFluorometer for clinical useRevoked2017-11-09
    Product approval · Class 1체외 제신 17-1291 호
  • MFDSFluorometer for clinical useRevoked2017-08-25
    Product approval · Class 1체외 제신 17-988 호
  • MFDSMicrobial susceptibility testing analyzer2016-08-01
    Product approval · Class 1체외 제신 16-936 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2016-06-21
    Product approval · Class 2체외 제허 16-440 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2016-06-21
    Product approval · Class 2체외 제인 16-441 호
  • MFDSIVD reagents and media for antibiotic susceptibilityRevoked2016-06-03
    Product approval · Class 2체외 제허 16-399 호
  • MFDSFluorometer for clinical use2015-12-02
    Product approval · Class 1체외 제신 15-469 호
  • MFDSMicrobial susceptibility testing analyzer2015-10-16
    Product approval · Class 1체외 제신 15-261 호
  • MFDSMicrobial susceptibility testing analyzerRevoked2015-06-02
    Product approval · Class 1서울 체외 제신 15-195 호
  • MFDSFluorometer for clinical useRevoked2014-09-03
    Product approval · Class 1서울 체외 제신 14-347 호
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

GC Medical Science Corporation8 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Boditech Med Inc.4 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

PROTIA INC.4 shared

KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.

GENEMATRIX INC.3 shared

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

HUMASIS CO., LTD.3 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

NanoenTek,Inc.3 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

SD BIOSENSOR INC.3 shared

KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.

Hanmi Science Co.,Ltd2 shared

KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.

PCL. Inc2 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

RollingStone Co., Ltd.2 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

Sugentech, Inc.2 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

Synergy Innovation Co., Ltd.2 shared

Synergy Innovation, founded in 1998 and KOSDAQ-listed in 2004, manufactures and sells microbial culture media.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition